Wonglhow, J.; Wong, H.-L.; Duong, C.; Spillane, J.; Liu, D.S.; Leong, T.; Chu, J.; Michael, M.
Real-World Outcomes Between Perioperative Chemotherapy (FLOT) and Preoperative Concurrent Chemoradiotherapy (CROSS) in Localized Esophageal and Esophagogastric Junction Adenocarcinoma: A Retrospective Cohort Study. Cancers 2025, 17, 2962.
https://doi.org/10.3390/cancers17182962
AMA Style
Wonglhow J, Wong H-L, Duong C, Spillane J, Liu DS, Leong T, Chu J, Michael M.
Real-World Outcomes Between Perioperative Chemotherapy (FLOT) and Preoperative Concurrent Chemoradiotherapy (CROSS) in Localized Esophageal and Esophagogastric Junction Adenocarcinoma: A Retrospective Cohort Study. Cancers. 2025; 17(18):2962.
https://doi.org/10.3390/cancers17182962
Chicago/Turabian Style
Wonglhow, Jirapat, Hui-Li Wong, Cuong Duong, John Spillane, David S. Liu, Trevor Leong, Julie Chu, and Michael Michael.
2025. "Real-World Outcomes Between Perioperative Chemotherapy (FLOT) and Preoperative Concurrent Chemoradiotherapy (CROSS) in Localized Esophageal and Esophagogastric Junction Adenocarcinoma: A Retrospective Cohort Study" Cancers 17, no. 18: 2962.
https://doi.org/10.3390/cancers17182962
APA Style
Wonglhow, J., Wong, H.-L., Duong, C., Spillane, J., Liu, D. S., Leong, T., Chu, J., & Michael, M.
(2025). Real-World Outcomes Between Perioperative Chemotherapy (FLOT) and Preoperative Concurrent Chemoradiotherapy (CROSS) in Localized Esophageal and Esophagogastric Junction Adenocarcinoma: A Retrospective Cohort Study. Cancers, 17(18), 2962.
https://doi.org/10.3390/cancers17182962
